Raymond James Financial Inc. increased its holdings in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 94.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,882,196 shares of the semiconductor company's stock after acquiring an additional 1,401,409 shares during the quarter. Raymond James Financial Inc. owned approximately 0.23% of Lam Research worth $209,535,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of LRCX. Smallwood Wealth Investment Management LLC bought a new stake in Lam Research during the first quarter worth $26,000. West Paces Advisors Inc. bought a new position in shares of Lam Research during the 4th quarter worth $27,000. Mpwm Advisory Solutions LLC purchased a new stake in Lam Research in the 4th quarter worth about $27,000. Park Square Financial Group LLC bought a new stake in Lam Research in the 4th quarter valued at about $31,000. Finally, Putney Financial Group LLC purchased a new stake in Lam Research during the fourth quarter valued at about $36,000. 84.61% of the stock is currently owned by institutional investors.
Lam Research Price Performance
Lam Research stock traded down $1.7270 during midday trading on Wednesday, hitting $98.6030. 8,212,629 shares of the company's stock were exchanged, compared to its average volume of 12,014,193. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $108.02. The stock has a 50-day moving average price of $97.90 and a two-hundred day moving average price of $84.22. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21. The company has a market cap of $124.79 billion, a P/E ratio of 23.70, a PEG ratio of 1.28 and a beta of 1.65.
Lam Research (NASDAQ:LRCX - Get Free Report) last posted its earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, topping the consensus estimate of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The business had revenue of $5.17 billion during the quarter, compared to analysts' expectations of $4.99 billion. During the same period in the previous year, the business earned $1.03 earnings per share. The firm's revenue was up 33.6% on a year-over-year basis. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. On average, equities research analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current year.
Wall Street Analysts Forecast Growth
LRCX has been the topic of several recent research reports. Erste Group Bank initiated coverage on shares of Lam Research in a report on Thursday, August 14th. They set a "buy" rating on the stock. Citigroup upped their price objective on shares of Lam Research from $108.00 to $113.00 and gave the company a "buy" rating in a report on Friday, August 1st. Morgan Stanley upped their price objective on shares of Lam Research from $87.00 to $94.00 and gave the company an "equal weight" rating in a report on Thursday, July 31st. Mizuho upped their price objective on shares of Lam Research from $115.00 to $120.00 and gave the company an "outperform" rating in a report on Friday, August 1st. Finally, Wells Fargo & Company set a $98.00 price target on Lam Research and gave the company an "equal weight" rating in a research report on Thursday, July 31st. Twenty investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $107.09.
Check Out Our Latest Research Report on Lam Research
About Lam Research
(
Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
See Also

Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.